Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Long-Term Investments (2017 - 2023)

vTv Therapeutics (VTVT) has disclosed Long-Term Investments for 7 consecutive years, with $4.4 million as the latest value for Q3 2023.

  • Quarterly Long-Term Investments fell 28.96% to $4.4 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Sep 2023, down 28.96% year-over-year, with the annual reading at $5.6 million for FY2022, 39.08% down from the prior year.
  • Long-Term Investments hit $4.4 million in Q3 2023 for vTv Therapeutics, down from $8.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $9.6 million in Q2 2021 to a low of $2.5 million in Q1 2019.
  • Historically, Long-Term Investments has averaged $5.4 million across 5 years, with a median of $5.8 million in 2022.
  • Biggest five-year swings in Long-Term Investments: skyrocketed 287.98% in 2021 and later crashed 40.01% in 2022.
  • Year by year, Long-Term Investments stood at $2.5 million in 2019, then soared by 171.17% to $6.7 million in 2020, then soared by 36.4% to $9.2 million in 2021, then crashed by 39.08% to $5.6 million in 2022, then dropped by 21.49% to $4.4 million in 2023.
  • Business Quant data shows Long-Term Investments for VTVT at $4.4 million in Q3 2023, $8.0 million in Q2 2023, and $7.7 million in Q1 2023.